Changqing Pan

P.R. China
Beijing, 100070, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Natural killer cell-specific chimeric antigen receptor enhances CAR NK cell functions and anti-tumor activity.

Natural killer cell-specific chimeric antigen receptor enhances CAR NK cell functions and anti-tumor activity.

Journal: Theranostics
Published: July 03, 2025

MS4A4A promotes macrophages M2 polarization via NF-κB /JAK-STAT6 axis, resulting GBM malignant progression.

MS4A4A promotes macrophages M2 polarization via NF-κB /JAK-STAT6 axis, resulting GBM malignant progression.

Journal: Oncogene
Published: May 10, 2025

Strategy and clinical benefit of first re-resection for recurrent adult-type diffuse glioma: A retrospective cohort analysis.

Strategy and clinical benefit of first re-resection for recurrent adult-type diffuse glioma: A retrospective cohort analysis.

Journal: Med (New York, N.Y.)
Published: March 14, 2025

The development and potent antitumor efficacy of CD44/CD133 dual-targeting IL7Rα-armored CAR-T cells against glioblastoma.

The development and potent antitumor efficacy of CD44/CD133 dual-targeting IL7Rα-armored CAR-T cells against glioblastoma.

Journal: Cancer letters
Published: November 18, 2024

Poliovirus receptor-based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastoma.

Poliovirus receptor-based chimeric antigen receptor T cells combined with NK-92 cells exert potent activity against glioblastoma.

Journal: Journal of the National Cancer Institute
Published: July 04, 2023

Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma.

Glycometabolic reprogramming-induced XRCC1 lactylation confers therapeutic resistance in ALDH1A3-overexpressing glioblastoma.

Journal: Cell metabolism
Published: June 28, 2023

Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape.

Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape.

Journal: Signal transduction and targeted therapy
Published: April 19, 2023

Diffuse Isocitrate Dehydrogenase-Mutant Gliomas With Histone H3 Alterations Are Distinguished by Unique Clinical Characteristics, Molecular Expression Profile, and Survival Prognosis.

Diffuse Isocitrate Dehydrogenase-Mutant Gliomas With Histone H3 Alterations Are Distinguished by Unique Clinical Characteristics, Molecular Expression Profile, and Survival Prognosis.

Journal: Neurosurgery
Published: November 09, 2022

Clinical characteristics and survival of glioblastoma complicated with non-central nervous system tumors.

Clinical characteristics and survival of glioblastoma complicated with non-central nervous system tumors.

Journal: Chinese neurosurgical journal
Published: October 28, 2022

Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion.

Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion.

Journal: Frontiers in immunology
Published: October 24, 2021

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas.

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas.

Journal: Frontiers in oncology
Published: July 31, 2021

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples.

Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples.

Journal: Cancer science
Published: June 28, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026